论文部分内容阅读
目的:观察米非司酮配伍缩宫素治疗植入性胎盘的临床效果。方法:选择符合条件的产妇术后或产后第1天口服米非司酮片50 mg,2次/日,共3天;同时肌注缩宫素10 U,2次/日(或静点缩宫素20 U,1次/日),观察宫缩、阴道出血及胎盘排出情况,监测血β-HCG,B超复查子宫内情况。停止服药4天后母乳喂养。结果:20例合并植入性胎盘的产妇,保守治疗全部成功,植入胎盘排出或吸收,无因产后出血或晚期产后出血行子宫切除,恶露量正常,持续时间较正常产妇稍延长,无产后感染发生,母乳喂养良好。结论:米非司酮配伍缩宫素治疗植入性胎盘是一种安全、简便、有效的方法,值得推广。
Objective: To observe the clinical effect of mifepristone combined with oxytocin in the treatment of implanted placenta. Methods: Mifepristone (50 mg) was given orally for 3 days postpartum or postpartum on the first day of postpartum. At the same time, oxytocin 10 U was intramuscularly injected twice a day Uterine hormone 20 U, 1 times / day), observed contractions, vaginal bleeding and placental discharge, monitoring of blood β-HCG, B-ultrasound intrauterine conditions. Stop feeding for 4 days after breastfeeding. Results: All the 20 pregnant women with implanted placenta were successfully treated by conservative treatment. The placenta was discharged or absorbed without hysterectomy due to postpartum hemorrhage or late postpartum hemorrhage. The amount of lochia was normal and the duration was slightly longer than that of normal maternal, Infection occurs, breastfeeding is good. Conclusion: The combination of mifepristone and oxytocin in the treatment of implanted placenta is a safe, simple and effective method that is worth promoting.